{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:05Z","timestamp":1788871865916,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007054","name":"Second Military Medical University","doi-asserted-by":"publisher","award":["2010QN05"],"award-info":[{"award-number":["2010QN05"]}],"id":[{"id":"10.13039\/501100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.yrtph.2014.07.024","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T22:15:10Z","timestamp":1407363310000},"page":"379-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute and subchronic toxicities of QX100626, a 5-HT4 receptor agonist, in rodents and Beagle dogs"],"prefix":"10.1016","volume":"70","author":[{"given":"Xiaofang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2014.07.024_b0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12012-002-0004-5","article-title":"Electrocardiographic and hemodynamic effects of cisapride alone and combined with erythromycin in anesthetized dogs","volume":"2","author":"Al-Wabel","year":"2002","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1542-3565(04)00391-X","article-title":"Effect of renzapride on transit in constipation-predominant irritable bowel syndrome","volume":"2","author":"Camilleri","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2006.00865.x","article-title":"Pharmacodynamic effects of a novel prokinetic 5-HT4 receptor agonist, ATI-7505, in humans","volume":"19","author":"Camilleri","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.yrtph.2014.07.024_b0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3565(24)36775-8","article-title":"Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?","volume":"282","author":"Carlsson","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10350-006-0763-3","article-title":"Serotonin and its role in colonic function and in gastrointestinal disorders","volume":"50","author":"Costedio","year":"2007","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.yrtph.2014.07.024_b0030","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0022-3565(25)20205-1","article-title":"Pharmacological characterization of a neuronal receptor to 5-hydroxytryptamine in guinea pig ileum with properties similar to 5-hydroxytryptamine 4 receptor","volume":"252","author":"Craig","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1476-5381.1990.tb14113.x","article-title":"Characterization of 5-HT3 and \u2018atypical\u2019 5-HT receptors mediating ileal contractions in vitro","volume":"101","author":"Eglen","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2003.12.028","article-title":"Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig","volume":"486","author":"Fossa","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2036.2008.03649.x","article-title":"Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome\u2013multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting","volume":"27","author":"George","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","article-title":"Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility","volume":"20","author":"Gershon","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yrtph.2014.07.024_b0060","doi-asserted-by":"crossref","first-page":"G319","DOI":"10.1152\/ajpgi.00326.2005","article-title":"Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT4 agonist tegaserod","volume":"290","author":"Grider","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5056\/jnm.2010.16.2.222","article-title":"Comments on tegaserod trial on irritable bowel syndrome","volume":"16","author":"Jung","year":"2010","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.yrtph.2014.07.024_b0070","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2011.01732.x","article-title":"Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome","volume":"23","author":"Kanazawa","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.yrtph.2014.07.024_b0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1124\/mol.105.012278","article-title":"Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels","volume":"68","author":"Lin","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0085","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1523\/JNEUROSCI.1145-09.2009","article-title":"5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice","volume":"29","author":"Liu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yrtph.2014.07.024_b0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2036.1991.tb00014.x","article-title":"The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis","volume":"5","author":"Mackie","year":"1991","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0095","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1476-5381.1991.tb12291.x","article-title":"5-Hydroxytryptamine-induced bronchoconstriction in the guinea-pig: effect of 5-HT2 receptor activation on acetylcholine release","volume":"102","author":"Macquin-Mavier","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/13543784.2010.482927","article-title":"New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders","volume":"19","author":"Manabe","year":"2010","journal-title":"Expert. Opin. Invest. Drugs"},{"key":"10.1016\/j.yrtph.2014.07.024_b0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)38802-0","article-title":"Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies","volume":"296","author":"Matsumoto","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0110","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/147323000703500613","article-title":"The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome","volume":"35","author":"Meyers","year":"2007","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.yrtph.2014.07.024_b0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.coph.2006.07.003","article-title":"Serotonergic receptors in therapeutic approaches to gastrointestinal disorders","volume":"6","author":"Neal","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1292\/jvms.09-0321","article-title":"Pharmacokinetics of the gastroprokinetic agent mosapride citrate after single oral administration in horses","volume":"72","author":"Okamura","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.yrtph.2014.07.024_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3346\/jkms.2009.24.3.403","article-title":"Effects of mixed herbal extracts from parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix (KIOM-79) on cardiac ion channels and action potentials","volume":"24","author":"Park","year":"2009","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.yrtph.2014.07.024_b0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29223-5","article-title":"Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K(+) channel","volume":"299","author":"Potet","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0130","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1476-5381.1996.tb15295.x","article-title":"Cisapride-induced prolongation of cardiac action potential and early after depolarizations in rabbit Purkinje fibres","volume":"117","author":"Puisieux","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cgh.2006.02.017","article-title":"Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies","volume":"4","author":"Quigley","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0140","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/sj.npp.1301644","article-title":"The promnesic effect of G-protein-coupled 5-HT4 receptors activation is mediated by a potentiation of learning-induced spine growth in the mouse hippocampus","volume":"33","author":"Restivo","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yrtph.2014.07.024_b0145","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00365520600641480","article-title":"Serotonin increases protective duodenal bicarbonate secretion via enteric ganglia and a 5-HT4-dependent pathway","volume":"41","author":"S\u00e4fsten","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1476-5381.2009.00427.x","article-title":"Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development","volume":"159","author":"Salvi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2036.2006.03095.x","article-title":"Influence of delaying gastric emptying on meal-related symptoms in healthy subjects","volume":"24","author":"Tack","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0160","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1365-2036.2006.02940.x","article-title":"Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome","volume":"23","author":"Tack","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2036.2012.05011.x","article-title":"Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders","volume":"35","author":"Tack","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2014.07.024_b0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1254\/jphs.SC0070243","article-title":"The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)- blocking activities","volume":"105","author":"Toga","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.yrtph.2014.07.024_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/1043-6618(91)90059-7","article-title":"Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action","volume":"24","author":"Tonini","year":"1991","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yrtph.2014.07.024_b0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0024-3205(92)90453-V","article-title":"5-Hydroxytryptamine 4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea-pig ileum: antagonism by tropisetron and DAU 6285","volume":"50","author":"Tonini","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2014.07.024_b0185","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0026-895X(25)09560-4","article-title":"5-Hydroxytryptamine 4 receptors reduce after hyperpolarization in hippocampus by inhibiting calcium-induced calcium release","volume":"50","author":"Torres","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"van Noord","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2014.07.024_b0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-2999(91)90175-P","article-title":"5-HT1 like receptors mediate potentiation of cholinergic nerve-mediated contraction of isolated mouse trachea","volume":"209","author":"Van Oosterhout","year":"1991","journal-title":"Eur. J. Pharmacol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230014001792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230014001792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:08:07Z","timestamp":1762283287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230014001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0273230014001792"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.07.024","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and subchronic toxicities of QX100626, a 5-HT4 receptor agonist, in rodents and Beagle dogs","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}